170 related articles for article (PubMed ID: 23045425)
21. Further delineation of achondroplasia-hypochondroplasia complex with long-term survival.
González-Del Angel A; Rius R; Alcántara-Ortigoza MA; Spector E; Del Castillo V; Mata-García LE
Am J Med Genet A; 2018 May; 176(5):1225-1231. PubMed ID: 29681095
[TBL] [Abstract][Full Text] [Related]
22. Mild achondroplasia/hypochondroplasia with acanthosis nigricans, normal development, and a p.Ser348Cys FGFR3 mutation.
Couser NL; Pande CK; Turcott CM; Spector EB; Aylsworth AS; Powell CM
Am J Med Genet A; 2017 Apr; 173(4):1097-1101. PubMed ID: 28181399
[TBL] [Abstract][Full Text] [Related]
23. Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia.
Heuertz S; Le Merrer M; Zabel B; Wright M; Legeai-Mallet L; Cormier-Daire V; Gibbs L; Bonaventure J
Eur J Hum Genet; 2006 Dec; 14(12):1240-7. PubMed ID: 16912704
[TBL] [Abstract][Full Text] [Related]
24. Familial hypochondroplasia and acanthosis nigricans with FGFR3 K650T mutation.
Cossiez Cacard MA; Coulombe J; Bernard P; Kaci N; Bressieux JM; Souchon PF; Motte J; Legeai-Mallet L; Hadj-Rabia S; Eschard C
J Eur Acad Dermatol Venereol; 2016 May; 30(5):897-8. PubMed ID: 25809207
[No Abstract] [Full Text] [Related]
25. Temporal and occipital lobe features in children with hypochondroplasia/FGFR3 gene mutation.
Philpott CM; Widjaja E; Raybaud C; Branson HM; Kannu P; Blaser S
Pediatr Radiol; 2013 Sep; 43(9):1190-5. PubMed ID: 23649205
[TBL] [Abstract][Full Text] [Related]
26. Does the co-occurrence of FGFR3 gene mutation in hypochondroplasia, medial temporal lobe dysgenesis, and focal epilepsy suggest a syndrome?
Romeo A; Lodi M; Viri M; Parente E; Baldi M; Righini A; Milani D
Pediatr Neurol; 2014 Apr; 50(4):427-30. PubMed ID: 24630288
[TBL] [Abstract][Full Text] [Related]
27. Monoallelic FGFR3 and Biallelic ALPL mutations in a Thai girl with hypochondroplasia and hypophosphatasia.
Porntaveetus T; Srichomthong C; Suphapeetiporn K; Shotelersuk V
Am J Med Genet A; 2017 Oct; 173(10):2747-2752. PubMed ID: 28763161
[TBL] [Abstract][Full Text] [Related]
28. Acanthosis nigricans, hypochondroplasia, and FGFR3 mutations: Findings with five new patients, and a review of the literature.
Muguet Guenot L; Aubert H; Isidor B; Toutain A; Mazereeuw-Hautier J; Collet C; Bourrat E; Denis Musquer M; Barbarot S;
Pediatr Dermatol; 2019 Mar; 36(2):242-246. PubMed ID: 30762251
[TBL] [Abstract][Full Text] [Related]
29. Criteria for radiologic diagnosis of hypochondroplasia in neonates.
Saito T; Nagasaki K; Nishimura G; Wada M; Nyuzuki H; Takagi M; Hasegawa T; Amano N; Murotsuki J; Sawai H; Yamada T; Sato S; Saitoh A
Pediatr Radiol; 2016 Apr; 46(4):513-8. PubMed ID: 26867606
[TBL] [Abstract][Full Text] [Related]
30. Children with short-limbed short stature in pediatric endocrinological services in Japan.
Hasegawa K; Tanaka H
Pediatr Int; 2014 Dec; 56(6):809-812. PubMed ID: 25244068
[TBL] [Abstract][Full Text] [Related]
31. Height outcome of short children with hypochondroplasia after recombinant human growth hormone treatment: a meta-analysis.
Massart F; Miccoli M; Baggiani A; Bertelloni S
Pharmacogenomics; 2015 Nov; 16(17):1965-73. PubMed ID: 26555758
[TBL] [Abstract][Full Text] [Related]
32. Genotype and phenotype in hypochondroplasia.
Ramaswami U; Rumsby G; Hindmarsh PC; Brook CG
J Pediatr; 1998 Jul; 133(1):99-102. PubMed ID: 9672519
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of growth hormone treatment in children with hypochondroplasia: comparison with an historical cohort.
Pinto G; Cormier-Daire V; Le Merrer M; Samara-Boustani D; Baujat G; Fresneau L; Viaud M; Souberbielle JC; Pineau JC; Polak M
Horm Res Paediatr; 2014; 82(6):355-63. PubMed ID: 25323764
[TBL] [Abstract][Full Text] [Related]
34. Familial acanthosis nigricans with the FGFR3 mutation: Differences of pigmentation between male and female patients.
Yasuda M; Morimoto N; Shimizu A; Toyoshima T; Yokoyama Y; Ishikawa O
J Dermatol; 2018 Nov; 45(11):1357-1361. PubMed ID: 30168875
[TBL] [Abstract][Full Text] [Related]
35. [Mutations in the Fibroblast Growth Factor Receptor 3 gene (FGFR3) in Chilean patients with idiopathic short stature, hypochondroplasia and achondroplasia].
Mancilla EE; Poggi H; Repetto G; García C; Foradori A; Cattani A
Rev Med Chil; 2003 Dec; 131(12):1405-10. PubMed ID: 15022403
[TBL] [Abstract][Full Text] [Related]
36. Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism.
Bonaventure J; Rousseau F; Legeai-Mallet L; Le Merrer M; Munnich A; Maroteaux P
Am J Med Genet; 1996 May; 63(1):148-54. PubMed ID: 8723101
[TBL] [Abstract][Full Text] [Related]
37. A novel missense mutation Ile538Val in the fibroblast growth factor receptor 3 in hypochondroplasia. Mutations in brief no. 122. Online.
Grigelioniené G; Hagenäs L; Eklöf O; Neumeyer L; Haereid PE; Anvret M
Hum Mutat; 1998; 11(4):333. PubMed ID: 10215410
[TBL] [Abstract][Full Text] [Related]
38. [Mutation analysis of FGFR3 gene in a family featuring hereditary dwarfism].
Zhang Q; Jiang HO; Quan QL; Li J; He T; Huang XS
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Dec; 28(6):705-7. PubMed ID: 22161110
[TBL] [Abstract][Full Text] [Related]
39. Comparison of clinical, radiological and molecular findings in Korean infants and children with achondroplasia and hypochondroplasia.
Shin YL; Choi JH; Kim GH; Yoo HW
J Pediatr Endocrinol Metab; 2005 Oct; 18(10):999-1005. PubMed ID: 16355813
[TBL] [Abstract][Full Text] [Related]
40. A common FGFR3 gene mutation in hypochondroplasia.
Prinos P; Costa T; Sommer A; Kilpatrick MW; Tsipouras P
Hum Mol Genet; 1995 Nov; 4(11):2097-101. PubMed ID: 8589686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
